- Home
- PLRX vs LNZA Comparison
PLRX vs LNZA Comparison
Compare PLRX & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | LNZA |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.5M | 61.2M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLRX | LNZA |
|---|---|---|
| Price | $1.14 | $6.68 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $2.67 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 367.4K | 61.9K |
| Earning Date | 05-06-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ 17.00 |
| Revenue | N/A | ★ $55,845,000.00 |
| Revenue This Year | N/A | $55.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.37 |
| Revenue Growth | N/A | ★ 12.61 |
| 52 Week Low | $1.02 | $5.02 |
| 52 Week High | $1.95 | $44.00 |
Technical Indicators
Market Signals| Indicator | PLRX | LNZA |
|---|---|---|
| Relative Strength Index (RSI) | 57.02 | 55.19 |
| Support Level | $1.12 | $5.38 |
| Resistance Level | $1.26 | $6.50 |
| Average True Range (ATR) | 0.04 | 0.39 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 57.14 | 77.17 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a provider of carbon management and conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical industrial inputs. Its mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging scalable biotechnology solutions to maximize the value of domestic resources. The company operates in North America, Europe, the Middle East, Africa (EMEA), Asia, and Australia, with the majority of its revenue generated from North America.